Heather Turner
2013 - Orexigen Therapeutics
In 2013, Heather Turner earned a total compensation of $1.6M as Former Senior Vice President, General Counsel and Secretary at Orexigen Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,900 |
|---|---|
| Option Awards | $1,028,448 |
| Salary | $370,000 |
| Other | $7,770 |
| Total | $1,617,118 |
Turner received $1M in option awards, accounting for 64% of the total pay in 2013.
Turner also received $210.9K in non-equity incentive plan, $370K in salary and $7.8K in other compensation.
Rankings
In 2013, Heather Turner's compensation ranked 4,640th out of 12,286 executives tracked by ExecPay. In other words, Turner earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,640 out of 12,286 | 62nd |
Division Manufacturing | 1,590 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 462 out of 1,466 | 69th |
Industry group Drugs | 323 out of 1,160 | 72nd |
Industry Pharmaceutical Preparations | 258 out of 890 | 71st |
Source: SEC filing on May 27, 2016.
Turner's colleagues
We found four more compensation records of executives who worked with Heather Turner at Orexigen Therapeutics in 2013.
2013
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2013
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2013
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
2013
Mark Booth
Orexigen Therapeutics